-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast
Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast
Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
Valuation and Earnings
This table compares Medtronic and Tivic Health Systems' gross revenue, earnings per share (EPS) and valuation.
Get Medtronic alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medtronic | $31.69 billion | 3.47 | $5.04 billion | $3.22 | 25.65 |
| Tivic Health Systems | $1.17 million | 6.12 | -$8.49 million | N/A | N/A |
Medtronic has higher revenue and earnings than Tivic Health Systems.
Risk and Volatility
Medtronic has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500.Insider and Institutional Ownership
80.4% of Medtronic shares are held by institutional investors. Comparatively, 0.2% of Tivic Health Systems shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 14.6% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Medtronic and Tivic Health Systems' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medtronic | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
Analyst Recommendations
This is a summary of recent ratings for Medtronic and Tivic Health Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medtronic | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
Medtronic presently has a consensus target price of $94.25, suggesting a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Tivic Health Systems.
Summary
Medtronic beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.
About Medtronic
(Get Rating)
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
About Tivic Health Systems
(Get Rating)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.
Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
美敦力(纽约证券交易所代码：MDT-GET评级)和蒂维奇健康系统(纳斯达克：TIVC-GET评级)都是医疗公司，但哪一家更好？我们将根据两家公司的机构所有权、风险、收益、盈利能力、分析师建议、股息和估值等方面的实力进行比较。
Valuation and Earnings
估值和收益
This table compares Medtronic and Tivic Health Systems' gross revenue, earnings per share (EPS) and valuation.
此表比较了美敦力和Tivic Health Systems的毛收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medtronic | $31.69 billion | 3.47 | $5.04 billion | $3.22 | 25.65 |
| Tivic Health Systems | $1.17 million | 6.12 | -$8.49 million | N/A | N/A |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 美敦力 | 316.9亿美元 | 3.47 | 50.4亿美元 | $3.22 | 25.65 |
| Tivic Health Systems | 117万美元 | 6.12 | -849万元 | 不适用 | 不适用 |
Medtronic has higher revenue and earnings than Tivic Health Systems.
美敦力的收入和收益高于Tivic Health Systems。
Risk and Volatility
风险和波动性
Insider and Institutional Ownership
内部人与机构持股
80.4% of Medtronic shares are held by institutional investors. Comparatively, 0.2% of Tivic Health Systems shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 14.6% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
美敦力80.4%的股份由机构投资者持有。相比之下，Tivic Health Systems 0.2%的股份由机构投资者持有。美敦力0.3%的股份由公司内部人士持有。相比之下，Tivic Health Systems 14.6%的股份由公司内部人士持有。强大的机构持股表明，对冲基金、捐赠基金和大型基金管理公司相信，一只股票有望实现长期增长。
Profitability
盈利能力
This table compares Medtronic and Tivic Health Systems' net margins, return on equity and return on assets.
此表比较了美敦力和Tivic Health Systems的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Medtronic | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 美敦力 | 14.03% | 13.52% | 7.77% |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
Analyst Recommendations
分析师建议
This is a summary of recent ratings for Medtronic and Tivic Health Systems, as provided by MarketBeat.com.
这是由MarketBeat.com提供的美敦力和Tivic Health Systems最近的评级摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medtronic | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 美敦力 | 1 | 14 | 5 | 0 | 2.20 |
| Tivic Health Systems | 0 | 0 | 0 | 0 | 不适用 |
Medtronic presently has a consensus target price of $94.25, suggesting a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Tivic Health Systems.
美敦力目前的普遍目标价为94.25美元，这意味着潜在的上涨幅度为14.13%。考虑到美敦力更有可能的上行空间，分析师们显然认为美敦力比Tivic Health Systems更有利。
Summary
摘要
Medtronic beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.
美敦力在两只股票比较的11个因素中有8个击败了Tivic Health Systems。
About Medtronic
美敦力简介
(Get Rating)
(获取评级)
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
美敦力是一家医疗科技公司，从事基于设备的医疗治疗和服务的开发、制造、分销和销售。它通过以下部门运作：心血管Porrtfolio、神经科学投资组合、医疗外科投资组合和糖尿病运营部门。心血管产品组合包括心律失常和心血管疾病的诊断、治疗和管理产品。神经科学产品组合由颅脑和脊柱技术、专业治疗和神经调节部门组成。医疗外科产品组合包括外科创新以及呼吸系统、胃肠道和肾脏部门。糖尿病组部门提供胰岛素泵、连续血糖监测系统和胰岛素泵消耗品。该公司成立于1949年，总部设在爱尔兰都柏林。
About Tivic Health Systems
关于Tivic Health Systems
(Get Rating)
(获取评级)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.是一家生物电子设备公司，提供用于治疗炎症情况的非侵入性神经调节产品。它的主要产品是Clearup，是一种旨在缓解鼻窦和鼻部炎症的医疗设备。该公司通过自己的网站、亚马逊(Amazon.com)和沃尔玛(Walmart.com)等平台以及BestBuy.com和FSAStore.com等美国在线零售商，通过直接面向消费者的渠道销售产品。Tivic Health Systems，Inc.成立于2016年，总部设在加利福尼亚州海沃德。
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.
接受美敦力日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对美敦力及相关公司评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧